Sr. Data Scientist, Assay Development
Salary: USD 130k–170k · Employer-posted
DELFI Diagnostics develops AI-powered liquid biopsy tests using fragmentomics technology to help detect cancer early through simple blood draws. Founded in 2019, DELFI Diagnostics is a precision oncology company that combines machine learning with genome-wide analysis of cell-free DNA fragments to develop accessible, high-performance cancer screening and treatment monitoring tests.
Follow DELFI Diagnostics, Inc.
Create an exact-company alert for on-site matches and optional daily email.
Salary: USD 130k–170k · Employer-posted